Malformation Panel
The Congenital Malformations & Dysmorphology Genetics Panel is a targeted Next-Generation Sequencing (NGS) assay engineered to comprehensively profile germline mutations across genes governing embryonic organogenesis, morphogenesis, and structural development. Congenital anomalies, dysmorphic facial features, skeletal dysplasias, and multi-organ malformation syndromes frequently originate from complex genetic disruptions. This panel resolves diagnostic ambiguity in patients with complex, overlapping, or atypical malformation phenotypes, providing an accurate molecular diagnosis, guiding multidisciplinary clinical care, establishing recurrence risks, and enabling reproductive planning for future pregnancies.
Key Features & Advantages
- Resolves Clinical & Phenotypic Heterogeneity: Delivers a definitive molecular diagnosis in patients presenting with overlapping dysmorphic traits, structural organ anomalies, or complex skeletal dysplasias.
- Ends the Diagnostic Odyssey: Eliminates years of repetitive, expensive, and invasive diagnostic procedures (imaging, biopsies) by pinpointing the underlying monogenic driver early in the clinical pathway.
- Precise Recurrence Risk Stratification: Delineates the exact mode of inheritance (autosomal dominant/recessive, X-linked, or de novo) to calculate precise recurrence risks and enable preimplantation genetic testing (PGT-M) or prenatal diagnostics (CVS/Amniocentesis) for future pregnancies.
- Informs Early Multidisiplinary Management: Uncovering the primary genetic etiology allows clinicians to proactively screen for anticipated systemic complications (e.g., occult cardiac defects, renal anomalies, vision or hearing impairment).
Malformations NGS Panel vs. Conventional Clinical & Cytogenetic Diagnostics
| Feature | Malformations Genetics Panel (NGS) | Standard Clinical & Cytogenetic Testing (Ultrasound, Physical Exam, Karyotype) |
| Diagnostic Scope | Single-nucleotide variants (SNVs) and indels in morphogenetic genes | Gross structural defects, anatomical anomalies, and large chromosomal aberrations |
| Etiological Resolution | High (Pinpoints the specific causative monogenic defect) | Phenotypic (Identifies structural anomalies without revealing the molecular driver) |
| Prognostic Value | High (Predicts future organ involvement, neurodevelopmental outcome, and disease trajectory) | Evaluates immediate physical presentation only |
| Reproductive Guidance | High (Provides specific target variants for PGT and prenatal diagnosis) | Low (Inability to identify specific mutation limits precise recurrence calculation) |
| Resolution Scale | Single-base resolution | Low (Standard karyotyping misses micro-deletions/insertions and single-gene mutations) |
Key Applications
- Multiple Congenital Anomaly Syndromes: Profiling complex multi-system disorders such as CHARGE, Cornelia de Lange, Rubinstein-Taybi, Noonan syndrome, and RASopathies.
- Skeletal Dysplasias & Bone Development Disorders: Molecular evaluation of Achondroplasia, Osteogenesis Imperfecta, Craniosynostosis syndromes, and limb anomalies (polydactyly, syndactyly).
- Craniofacial Malformation Syndromes: Comprehensive screening for cleft lip/palate syndromes, Treacher Collins, Apert, Pfeiffer, and Crouzon syndromes.
- Central Nervous System Structural Malformations: Genotyping for Holoprosencephaly, Lissencephaly, Agenesis of the Corpus Callosum, and neuronal migration defects.
- Urogenital & Congenital Cardiac Malformations: Screening genetic etiologies behind syndromic congenital heart defects, renal agenesis, and structural urogenital anomalies.
The Nucleus Genetics Advantage: Combining broad target NGS panels tailored for dysmorphology and dysmorphology, advanced HPO-integrated bioinformatic pipelines, and expert curation by medical and pediatric geneticists, we transform complex developmental data into actionable clinical insights.
Get Information About This Service
Our expert team is ready to answer your questions and offer tailored solutions.
Contact Form →